User: Guest  Login
Title:

COVID-19 pandemic and allergen immunotherapy-an EAACI survey.

Document type:
Article; Journal Article
Author(s):
Pfaar, Oliver; Agache, Ioana; Bonini, Matteo; Brough, Helen Annaruth; Chivato, Tomás; Del Giacco, Stefano R; Gawlik, Radoslaw; Gelincik, Asli; Hoffmann-Sommergruber, Karin; Jutel, Marek; Klimek, Ludger; Knol, Edward F; Lauerma, Antti; Ollert, Markus; O'Mahony, Liam; Mortz, Charlotte G; Palomares, Oscar; Riggioni, Carmen; Schwarze, Jürgen; Skypala, Isabel; Torres, María José; Untersmayr, Eva; Walusiak-Skorupa, Jolanta; Chaker, Adam; Giovannini, Mattia; Heffler, Enrico; Jensen-Jarolim, Erika; Quec...     »
Abstract:
BACKGROUND: As in many fields of medical care, the coronavirus disease 2019 (COVID-19) resulted in an increased uncertainty regarding the safety of allergen immunotherapy (AIT). Therefore, the European Academy of Allergy and Clinical Immunology (EAACI) aimed to analyze the situation in different countries and to systematically collect all information available regarding tolerability and possible amendments in daily practice of sublingual AIT (SLIT), subcutaneous AIT (SCIT) for inhalant allergies...     »
Journal title abbreviation:
Allergy
Year:
2021
Journal volume:
76
Journal issue:
11
Pages contribution:
3504-3516
Fulltext / DOI:
doi:10.1111/all.14793
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/33655519
Print-ISSN:
0105-4538
TUM Institution:
Molekulare Allergologie (Prof. Schmidt-Weber)
 BibTeX